In recent times, research on brain injury has garnered significant attention, particularly for understanding the cellular and molecular changes that are associated with neurological diseases. In this ...

Brain injury is a common pathological process during neurological diseases. Understanding the biomarkers produced after a brain injury may not only help in the diagnosis of the disease but can also ...

Monash University-led research, believed to be the first of its kind, has used blood tests and MRI scans to show that the effects of traumatic brain injuries (TBI) can last decades. Published in Brain ...

The levels of biomarkers GFAP, UCH-L1, and MAP-2 are significantly elevated within 30 and 60 minutes of traumatic brain injury (TBI), thereby facilitating early diagnosis. GFAP demonstrates the ...

The Forum on Traumatic Brain Injury hosted a 1-day workshop exploring biomarkers to more precisely and objectively diagnose and categorize a suspected TBI, better guide and monitor treatment after ...

Researchers have developed a chip-based metasurface biosensor that can detect traumatic brain injury (TBI) biomarkers at extremely low levels. With further development, the technology could one day ...

When a newborn baby begins experiencing respiratory problems, lethargy, or seizures after an acute perinatal event or difficult labor, the clock starts ticking. 1 Physicians must rapidly evaluate the ...

For millions of people living with the long-term effects of traumatic brain injury (TBI), the prevailing belief has been that chronic neuroinflammation causes recovery to plateau over time, meaning ...

Additional studies presented at AAIC 2026 link greater heading exposure and longer soccer careers with biomarkers of neural injury, tau accumulation and chronic traumatic encephalopathy (CTE) risk.